$1.99
-0.01 (-0.50%)
Open$1.96
Previous Close$2.00
Day High$2.02
Day Low$1.96
52W High$4.59
52W Low$1.67
Volume—
Avg Volume9.1K
Market Cap4.88M
P/E Ratio—
EPS$-2.06
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,961.8% upside
Current
$1.99
$1.99
Target
$41.03
$41.03
$36.60
$41.03 avg
$68.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.4K | 53.5K | 1.35M |
| Net Income | -5,273,805 | -39,685,823 | -84,207 |
| Profit Margin | -83,520.0% | -79,344.0% | -6.2% |
| EBITDA | -5,326,954 | -42,312,761 | -111,401 |
| Free Cash Flow | — | — | -113,905 |
| Rev Growth | -88.0% | -88.0% | +20.4% |
| Debt/Equity | — | — | 1.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.68 | -0.45% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $412.84 | -1.20% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.12 | -0.01% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $508.33 | -1.57% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.64 | -0.29% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.29 | +0.07% | 35.2 | 28.41B |